Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Visser

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Pathogens (Basel, Switzerland)|April 14, 2018
The Microenvironment in Epstein-Barr Virus-Associated MalignanciesGeok Wee Tan, Lydia Visser, Lu Ping Tan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2014
Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanismsKushi Kushekhar, Anke van den Berg, Ilja Nolte, et al.
Journal of Hematology & Oncology|August 13, 2014
Toll-like receptors in the pathogenesis of human B cell malignanciesJohana M Isaza-Correa, Zheng Liang, Anke van den Berg, et al.
International Journal of Molecular Sciences|November 26, 2022
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin LymphomaMyra Langendonk, Nienke A M Smit, Wouter Plattel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 26, 2008
The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profileYue Ma, Lydia Visser, Tjasso Blokzijl, et al.
Journal of Clinical Pathology|December 13, 2006
Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartmentsCigdem Atayar, Anke van den Berg, Tjasso Blokzijl, et al.
Plos One|February 4, 2014
Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphomaZheng Liang, Arjan Diepstra, Chuanhui Xu, et al.
Blood|June 27, 2020
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58Johanna Veldman, Lydia Visser, Magdalena Huberts-Kregel, et al.
International Journal of Cancer|July 13, 2002
Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomasEwerton M Maggio, Anke Van Den Berg, Lydia Visser, et al.
British Journal of Haematology|February 23, 2021
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphomaJohanna Veldman, Zainab N D Alsada, Anke van den Berg, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Pathogens (Basel, Switzerland)|April 14, 2018
The Microenvironment in Epstein-Barr Virus-Associated MalignanciesGeok Wee Tan, Lydia Visser, Lu Ping Tan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2014
Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanismsKushi Kushekhar, Anke van den Berg, Ilja Nolte, et al.
Journal of Hematology & Oncology|August 13, 2014
Toll-like receptors in the pathogenesis of human B cell malignanciesJohana M Isaza-Correa, Zheng Liang, Anke van den Berg, et al.
International Journal of Molecular Sciences|November 26, 2022
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin LymphomaMyra Langendonk, Nienke A M Smit, Wouter Plattel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 26, 2008
The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profileYue Ma, Lydia Visser, Tjasso Blokzijl, et al.
Journal of Clinical Pathology|December 13, 2006
Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartmentsCigdem Atayar, Anke van den Berg, Tjasso Blokzijl, et al.
Plos One|February 4, 2014
Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphomaZheng Liang, Arjan Diepstra, Chuanhui Xu, et al.
Blood|June 27, 2020
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58Johanna Veldman, Lydia Visser, Magdalena Huberts-Kregel, et al.
International Journal of Cancer|July 13, 2002
Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomasEwerton M Maggio, Anke Van Den Berg, Lydia Visser, et al.
British Journal of Haematology|February 23, 2021
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphomaJohanna Veldman, Zainab N D Alsada, Anke van den Berg, et al.
Pageof 8